Sprycel
Generic Content-Dasatinib, Manufactured By: BMS,USA

Sprycel is indicated for the treatment of adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase and acute lymphoblastic leukemia (ALL).

Available As: 50 Mg Tablet & 70 Mg Tablet